BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24695851)

  • 1. MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia.
    Manara E; Baron E; Tregnago C; Aveic S; Bisio V; Bresolin S; Masetti R; Locatelli F; Basso G; Pigazzi M
    Blood; 2014 Jul; 124(2):263-72. PubMed ID: 24695851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6.
    Liedtke M; Ayton PM; Somervaille TC; Smith KS; Cleary ML
    Blood; 2010 Jul; 116(1):63-70. PubMed ID: 20395419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l.
    Deshpande AJ; Chen L; Fazio M; Sinha AU; Bernt KM; Banka D; Dias S; Chang J; Olhava EJ; Daigle SR; Richon VM; Pollock RM; Armstrong SA
    Blood; 2013 Mar; 121(13):2533-41. PubMed ID: 23361907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11) (q27;q23) leukemia localize in the nucleus.
    Joh T; Yamamoto K; Kagami Y; Kakuda H; Sato T; Yamamoto T; Takahashi T; Ueda R; Kaibuchi K; Seto M
    Oncogene; 1997 Oct; 15(14):1681-7. PubMed ID: 9349501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of AF6-RAS association and its implications in mixed-lineage leukemia.
    Smith MJ; Ottoni E; Ishiyama N; Goudreault M; Haman A; Meyer C; Tucholska M; Gasmi-Seabrook G; Menezes S; Laister RC; Minden MD; Marschalek R; Gingras AC; Hoang T; Ikura M
    Nat Commun; 2017 Oct; 8(1):1099. PubMed ID: 29062045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MLL-AF6 fusion resulting from a new three-way translocation t(6;11;7) in a patient with acute myeloid leukemia.
    Giugliano E; Rege-Cambrin G; Scaravaglio P; Serra A; Wlodarska I; Emanuel B; Saglio G; Hagemeijer A
    Leukemia; 2001 Oct; 15(10):1674-6. PubMed ID: 11587234
    [No Abstract]   [Full Text] [Related]  

  • 7. The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia.
    Numata A; Kwok HS; Kawasaki A; Li J; Zhou QL; Kerry J; Benoukraf T; Bararia D; Li F; Ballabio E; Tapia M; Deshpande AJ; Welner RS; Delwel R; Yang H; Milne TA; Taneja R; Tenen DG
    Nat Commun; 2018 Apr; 9(1):1622. PubMed ID: 29692408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of the rearranged genome and chimeric mRNAs caused by the t(6;11)(q27;q23) chromosome translocation involving MLL in an infant acute monocytic leukemia.
    Akao Y; Isobe M
    Genes Chromosomes Cancer; 2000 Apr; 27(4):412-7. PubMed ID: 10719372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal origin of KRAS mutation in a child with an acute myelomonocytic leukaemia bearing the KMT2A/MLL-AFDN/MLLT4/AF6 fusion transcript.
    Andriano N; Iachelli V; Bonaccorso P; La Rosa M; Meyer C; Marschalek R; Lo Nigro L
    Br J Haematol; 2019 May; 185(3):563-566. PubMed ID: 30132801
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical characteristics and prognosis of
    Zhang MX; Shi WZ; Liu JX; Wang CJ; Li Y; Wang W; Jiang B
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 53(5):915-920. PubMed ID: 34650294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a MLL-MLLT4 fusion gene resulting from a t(6;11)(q27;q23) presenting as a del(11q) in a child with T-cell acute lymphoblastic leukemia.
    De Braekeleer E; Meyer C; Le Bris MJ; Douet-Guilbert N; Basinko A; Morel F; Berthou C; Marschalek R; Férec C; De Braekeleer M
    Leuk Lymphoma; 2010 Aug; 51(8):1570-3. PubMed ID: 20545580
    [No Abstract]   [Full Text] [Related]  

  • 12. Frat2 mediates the oncogenic activation of Rac by MLL fusions.
    Walf-Vorderwülbecke V; de Boer J; Horton SJ; van Amerongen R; Proost N; Berns A; Williams O
    Blood; 2012 Dec; 120(24):4819-28. PubMed ID: 23074275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction.
    Mitterbauer G; Zimmer C; Pirc-Danoewinata H; Haas OA; Hojas S; Schwarzinger I; Greinix H; Jäger U; Lechner K; Mannhalter C
    Br J Haematol; 2000 Jun; 109(3):622-8. PubMed ID: 10886213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the t(6;11)(q27;q23) in leukemia shows a consistent breakpoint in AF6 in three patients and in the ML-2 cell line.
    Tanabe S; Zeleznik-Le NJ; Kobayashi H; Vignon C; Espinosa R; LeBeau MM; Thirman MJ; Rowley JD
    Genes Chromosomes Cancer; 1996 Apr; 15(4):206-16. PubMed ID: 8703846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioridazine requires calcium influx to induce MLL-AF6-rearranged AML cell death.
    Tregnago C; Da Ros A; Porcù E; Benetton M; Simonato M; Simula L; Borella G; Polato K; Minuzzo S; Borile G; Cogo P; Campello S; Massi A; Romagnoli R; Buldini B; Locatelli F; Pigazzi M
    Blood Adv; 2020 Sep; 4(18):4417-4429. PubMed ID: 32931582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel RAS GTPase-activating protein (RASGAP) gene at 9q34 as an MLL fusion partner in a patient with de novo acute myeloid leukemia.
    von Bergh AR; Wijers PM; Groot AJ; van Zelderen-Bhola S; Falkenburg JH; Kluin PM; Schuuring E
    Genes Chromosomes Cancer; 2004 Apr; 39(4):324-34. PubMed ID: 14978793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AF6 gene on chromosome band 6q27 maps distal to the minimal region of deletion in epithelial ovarian cancer.
    Saha V; Lillington DM; Shelling AN; Chaplin T; Yaspo ML; Ganesan TS; Young BD
    Genes Chromosomes Cancer; 1995 Nov; 14(3):220-2. PubMed ID: 8589040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
    Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
    Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia.
    Kim WI; Matise I; Diers MD; Largaespada DA
    Blood; 2009 Jan; 113(5):1086-96. PubMed ID: 18952898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring minimal residual disease in patients with MLL-AF6 fusion transcript-positive acute myeloid leukemia following allogeneic bone marrow transplantation.
    Takatsuki H; Yufu Y; Tachikawa Y; Uike N
    Int J Hematol; 2002 Apr; 75(3):298-301. PubMed ID: 11999359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.